PATHEON N.V. (PTHN) financial statements (2020 and earlier)

Company profile

Business Address EVERT VAN DE BEEKSTRAAT 104
AMSTERDAM SCHIPHOL, 1118 CN
State of Incorp.
Fiscal Year End October 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

10/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments166
Cash and cash equivalents165
Short-term investments1
Receivables410
Inventory, net of allowances, customer advances and progress billings395
Inventory395
Other undisclosed current assets20
Total current assets:991
Noncurrent Assets
Property, plant and equipment984
Long-term investments and receivables12
Long-term investments12
Intangible assets, net (including goodwill)529
Goodwill282
Intangible assets, net (excluding goodwill)248
Other noncurrent assets44
Other undisclosed noncurrent assets80
Total noncurrent assets:1,649
TOTAL ASSETS:2,640
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:394
Accounts payable279
Accrued liabilities9
Employee-related liabilities82
Taxes payable7
Interest and dividends payable14
Other undisclosed accounts payable and accrued liabilities3
Debt20
Deferred revenue and credits154
Other undisclosed current liabilities7
Total current liabilities:574
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,100
Other undisclosed long-term debt and lease obligation2,100
Liabilities, other than long-term debt248
Deferred revenue and credits102
Other liabilities146
Other undisclosed noncurrent liabilities67
Total noncurrent liabilities:2,414
Total liabilities:2,988
Stockholders' equity
Stockholders' equity attributable to parent(348)
Common stock2
Additional paid in capital591
Accumulated other comprehensive loss(99)
Accumulated deficit(842)
Total stockholders' equity:(348)
TOTAL LIABILITIES AND EQUITY:2,640

Income statement (P&L) ($ in millions)

10/31/2016
Revenues
(Revenue, Net)
1,867
Cost of revenue
(Cost of Goods and Services Sold)
(1,321)
Gross profit:546
Operating expenses(332)
Other operating income, net1
Other undisclosed operating loss(17)
Operating income:198
Nonoperating expense(5)
Foreign currency transaction loss, before tax(6)
Other nonoperating income1
Interest and debt expense(22)
Income from continuing operations before equity method investments, income taxes:171
Other undisclosed loss from continuing operations before income taxes(160)
Income from continuing operations before income taxes:11
Income tax benefit24
Net income:35
Other undisclosed net loss attributable to parent(3)
Net income available to common stockholders, diluted:32

Comprehensive Income ($ in millions)

10/31/2016
Net income:35
Other comprehensive loss(76)
Comprehensive loss:(41)
Other undisclosed comprehensive income, net of tax, attributable to parent47
Comprehensive income, net of tax, attributable to parent:6

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: